Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Sanofi Pasteur H1N1 Vaccine in Pregnant Women
NCT00963430Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Sep 2009
- Primary completion
- May 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of CSL H1N1 Pandemic Influenza Vaccine in influenza, sponsored by National Institute of Allergy and Infectious Diseases. Started Sep 2009; status: completed.
02
Drugs
CSL H1N1 Pandemic Influenza Vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00963430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00963430.